{"AllianceGenome": "25941", "HGNC": "25941", "MIM": "612839", "_id": "54790", "_version": 2, "accession": {"genomic": ["AC004069.1", "AC026029.8", "CH471057.1", "CP068274.2", "LT746172.1", "LT746173.1", "LT746174.1", "LT746175.1", "LT746176.1", "LT746177.1", "LT746178.1", "LT746179.1", "LT746181.1", "LT746182.1", "LT746183.1", "LT746184.1", "LT746185.1", "LT746186.1", "LT746187.1", "NC_000004.12", "NC_060928.1", "NG_028191.1"], "protein": ["AAI10510.1", "AAI10511.2", "AAI50181.1", "AAI50202.1", "BAA90898.1", "BAB13372.1", "BAB55391.1", "BAE45750.1", "CAE45851.1", "CAX30492.1", "EAX06177.1", "EAX06178.1", "EAX06179.1", "NP_001120680.1", "NP_060098.3", "Q6N021.3", "XP_005263139.1", "XP_006714305.1", "XP_016863808.1", "XP_024309870.1", "XP_024309871.1", "XP_047271795.1", "XP_047271796.1", "XP_047271797.1", "XP_047271798.1", "XP_047271799.1", "XP_054206247.1", "XP_054206248.1", "XP_054206249.1", "XP_054206250.1", "XP_054206251.1", "XP_054206252.1", "XP_054206253.1", "XP_054206254.1", "XP_054206255.1", "XP_054206256.1"], "rna": ["AB046766.1", "AB075496.1", "AI084057.1", "AK000039.1", "AK027819.1", "AK055149.1", "BC019007.2", "BC110509.1", "BC110510.2", "BC150180.1", "BC150201.1", "BQ006500.1", "BX640738.1", "DA391215.1", "DR000714.1", "DR005542.1", "FM992369.1", "NM_001127208.3", "NM_017628.4", "XM_005263082.4", "XM_006714242.4", "XM_017008319.2", "XM_024454102.2", "XM_024454103.2", "XM_047415839.1", "XM_047415840.1", "XM_047415841.1", "XM_047415842.1", "XM_047415843.1", "XM_054350272.1", "XM_054350273.1", "XM_054350274.1", "XM_054350275.1", "XM_054350276.1", "XM_054350277.1", "XM_054350278.1", "XM_054350279.1", "XM_054350280.1", "XM_054350281.1", "XR_007057933.1", "XR_008486995.1"], "translation": [{"protein": "XP_047271798.1", "rna": "XM_047415842.1"}, {"protein": "XP_054206252.1", "rna": "XM_054350277.1"}, {"protein": "XP_047271795.1", "rna": "XM_047415839.1"}, {"protein": "CAX30492.1", "rna": "FM992369.1"}, {"protein": "XP_047271797.1", "rna": "XM_047415841.1"}, {"protein": "XP_054206254.1", "rna": "XM_054350279.1"}, {"protein": "XP_054206256.1", "rna": "XM_054350281.1"}, {"protein": "AAI10510.1", "rna": "BC110509.1"}, {"protein": "BAE45750.1", "rna": "AB075496.1"}, {"protein": "CAE45851.1", "rna": "BX640738.1"}, {"protein": "AAI50202.1", "rna": "BC150201.1"}, {"protein": "NP_001120680.1", "rna": "NM_001127208.3"}, {"protein": "XP_054206248.1", "rna": "XM_054350273.1"}, {"protein": "AAI10511.2", "rna": "BC110510.2"}, {"protein": "XP_047271799.1", "rna": "XM_047415843.1"}, {"protein": "XP_054206253.1", "rna": "XM_054350278.1"}, {"protein": "XP_005263139.1", "rna": "XM_005263082.4"}, {"protein": "AAI50181.1", "rna": "BC150180.1"}, {"protein": "XP_054206249.1", "rna": "XM_054350274.1"}, {"protein": "XP_054206255.1", "rna": "XM_054350280.1"}, {"protein": "XP_054206250.1", "rna": "XM_054350275.1"}, {"protein": "BAB55391.1", "rna": "AK027819.1"}, {"protein": "XP_024309870.1", "rna": "XM_024454102.2"}, {"protein": "BAB13372.1", "rna": "AB046766.1"}, {"protein": "XP_024309871.1", "rna": "XM_024454103.2"}, {"protein": "XP_016863808.1", "rna": "XM_017008319.2"}, {"protein": "NP_060098.3", "rna": "NM_017628.4"}, {"protein": "XP_054206251.1", "rna": "XM_054350276.1"}, {"protein": "XP_054206247.1", "rna": "XM_054350272.1"}, {"protein": "XP_047271796.1", "rna": "XM_047415840.1"}, {"protein": "BAA90898.1", "rna": "AK000039.1"}, {"protein": "XP_006714305.1", "rna": "XM_006714242.4"}]}, "alias": ["IMD75", "KIAA1546", "MDS"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "moderate", "classification_date": "2022-11-03T16:00:00.000Z", "disease_label": "pulmonary arterial hypertension", "gcep": "Pulmonary Hypertension Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0015924", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0c056edd-f72b-43e9-ba40-7504f285cf5a-2022-11-03T160000.000Z", "sop": "SOP9"}}, "ec": "1.14.11.80", "ensembl": {"gene": "ENSG00000168769", "protein": ["ENSP00000265149", "ENSP00000306705", "ENSP00000369351", "ENSP00000391448", "ENSP00000425443", "ENSP00000426885", "ENSP00000442788"], "transcript": ["ENST00000265149", "ENST00000305737", "ENST00000380013", "ENST00000413648", "ENST00000504042", "ENST00000505801", "ENST00000513237", "ENST00000514870", "ENST00000540549"], "translation": [{"protein": "ENSP00000306705", "rna": "ENST00000305737"}, {"protein": "ENSP00000425443", "rna": "ENST00000513237"}, {"protein": "ENSP00000442788", "rna": "ENST00000540549"}, {"protein": "ENSP00000265149", "rna": "ENST00000265149"}, {"protein": "ENSP00000369351", "rna": "ENST00000380013"}, {"protein": "ENSP00000391448", "rna": "ENST00000413648"}, {"protein": "ENSP00000426885", "rna": "ENST00000514870"}], "type_of_gene": "protein_coding"}, "entrezgene": "54790", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 20.9853585108, "exp_mis": 301.252100908, "exp_syn": 117.153786546, "lof_z": -2.3817811014798, "mis_z": -1.14830338168869, "mu_lof": 3.51378164749e-06, "mu_mis": 5.00270068998e-05, "mu_syn": 1.93299721205e-05, "n_lof": 32.0, "n_mis": 342.0, "n_syn": 133.0, "p_li": 7.05368251291393e-26, "p_null": 0.999996330551251, "p_rec": 3.66944874941071e-06, "syn_z": -0.907604027215316}, "bp": 6009, "cds_end": 106197676, "cds_start": 106155099, "n_exons": 9, "nonpsych": {"exp_lof": 18.9713028969, "exp_mis": 272.639757873, "exp_syn": 106.013011559, "lof_z": -2.035768935919, "mis_z": -1.04959734163671, "mu_lof": 3.51378164749e-06, "mu_mis": 5.00270068998e-05, "mu_syn": 1.93299721205e-05, "n_lof": 28.0, "n_mis": 307.0, "n_syn": 127.0, "p_li": 2.04817778847154e-22, "p_null": 0.9999730229542, "p_rec": 2.69770457995747e-05, "syn_z": -1.28331796152362}, "nontcga": {"exp_lof": 19.3043407802, "exp_mis": 277.14976337, "exp_syn": 107.779299766, "lof_z": -1.50330514134997, "mis_z": -0.833453691805364, "mu_lof": 3.51378164749e-06, "mu_mis": 5.00270068998e-05, "mu_syn": 1.93299721205e-05, "n_lof": 26.0, "n_mis": 305.0, "n_syn": 119.0, "p_li": 3.39557481956966e-20, "p_null": 0.999839567235038, "p_rec": 0.000160432764962324, "syn_z": -0.684344181941234}, "transcript": "ENST00000540549.1"}, "exons": [{"cdsend": 105276519, "cdsstart": 105233942, "chr": "4", "position": [[105146875, 105146979], [105190359, 105190505], [105233896, 105237351], [105241338, 105241429], [105242833, 105242927], [105243569, 105243778], [105259618, 105259769], [105261758, 105261848], [105269609, 105269747], [105272563, 105272918], [105275047, 105279803]], "strand": 1, "transcript": "NM_001127208", "txend": 105279803, "txstart": 105146875}, {"cdsend": 105237440, "cdsstart": 105233942, "chr": "4", "position": [[105145874, 105146086], [105190359, 105190505], [105233896, 105242771]], "strand": 1, "transcript": "NM_017628", "txend": 105242771, "txstart": 105145874}], "exons_hg19": [{"cdsend": 106197676, "cdsstart": 106155099, "chr": "4", "position": [[106068032, 106068136], [106111516, 106111662], [106155053, 106158508], [106162495, 106162586], [106163990, 106164084], [106164726, 106164935], [106180775, 106180926], [106182915, 106183005], [106190766, 106190904], [106193720, 106194075], [106196204, 106200960]], "strand": 1, "transcript": "NM_001127208", "txend": 106200960, "txstart": 106068032}, {"cdsend": 106158597, "cdsstart": 106155099, "chr": "4", "position": [[106067031, 106067243], [106111516, 106111662], [106155053, 106163928]], "strand": 1, "transcript": "NM_017628", "txend": 106163928, "txstart": 106067031}], "generif": [{"pubmed": 19262599, "text": "Loss-of-function mutations in TET2 occur at a high frequency in systemic mastocytosis, and are associated with KITD816V mutations."}, {"pubmed": 19262599, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19262601, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19262601, "text": "TET2 mutations occur in both JAK2V617F-positive and -negative myeloproliferative neoplasms."}, {"pubmed": 19295549, "text": "looked for the presence of TET2 mutations in myeloid malignancies other than MPN, including chronic myelomonocytic leukemia (CMML), myelodysplastic syndrome (MDS), 'MDS/MPN' and acute myeloid leukemia (AML)"}, {"pubmed": 19372255, "text": "TET2 mutations were found in patients with MDS/MPN including CMML or sAML evolved from MDS/MPN and typical MDS, suggesting they may play a ubiquitous role in malignant evolution."}, {"pubmed": 19420352, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19420352, "text": "Sequencing of TET2 in 408 paired tumor/normal samples distinguished between 68 somatic mutations and 6 novel single nucleotide polymorphisms and identified TET2 mutations in MPN (7.6%), CMML (42%), AML (12%), and M7 AML (3.6%) samples."}, {"pubmed": 19474426, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19474426, "text": "Somatic mutations in TET2 occur in about 15% of patients with various myeloid cancers."}, {"pubmed": 19483684, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19483684, "text": "TET2 is the most frequently mutated gene in Myelodysplastic syndromes known so far."}, {"pubmed": 19528370, "text": "Novel TET2 mutations associated with UPD4q24 in myelodysplastic syndrome."}, {"pubmed": 19564637, "text": "TET2 mutations were mainly observed (10 of 12) in patients with primary myelofibrosis or patients with polycythemia vera or essential thrombocythemia who secondarily evolved toward myelofibrosis or acute myeloid leukemia."}, {"pubmed": 19609284, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19666869, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19666869, "text": "TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes"}, {"pubmed": 19710701, "text": "TET2 mutations are not observed in all cases of JAK2V617F-negative acute myeloblastic leukemia (AML) that develops from myeloproliferative neoplasms (MPN)."}, {"pubmed": 19767753, "text": "Observational study and meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19797729, "text": "Data show that TET2 gene alterations are more frequent in chronic myelomonocytic leukemia than in other subgroups of hematopoietic diseases studied so far and could negatively affect the patients' outcome."}, {"pubmed": 19849974, "text": "Mutated in myeloid cancers and other myeloproliferative disorders."}, {"pubmed": 19903679, "text": "High frequency of TET2 mutations are associated with refractory anemia with ring sideroblasts and thrombocytosis."}, {"pubmed": 19923888, "text": "TET family influences DNA methylation in hematopoietic malignancy"}, {"pubmed": 19957346, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19957346, "text": "TET2(tet oncogene family member 2) mutations do not affect initial or subsequent cytogenetic findings in myeloproliferative neoplasms"}, {"pubmed": 20008299, "text": "Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia."}, {"pubmed": 20061559, "text": "The lack of a strict temporal order of occurrence makes it unlikely that mutations in TET2 represent a predisposing event for acquiring mutations in JAK2."}, {"pubmed": 20093295, "text": "TET2 mutations were associated with idic(X)-positive myeloid malignancies."}, {"pubmed": 20156304, "text": "the occurrence of TET2 mutations may represent an early event in the pathogenesis of the myeloproliferative neoplasms and splanchnic vein thrombosis"}, {"pubmed": 20171768, "text": "JAK2 and TET2 mutations in myelodysplastic syndromes [review]"}, {"pubmed": 20195608, "text": "Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignancies."}, {"pubmed": 20332099, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20334914, "text": "TET2 mutations are associated with refractory anemia with ring sideroblasts and thrombocytosis."}, {"pubmed": 20489055, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20489055, "text": "TET2 point mutations are associated with acute myeloid leukemia."}, {"pubmed": 20508616, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 20564319, "text": "Meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20595094, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20595094, "text": "TET2 is not deleted in CMML patients, although it is mutated in a high proportion of cases"}, {"pubmed": 20629097, "text": "TET2 mutations are not associated with transformed myeloproliferative neoplasms."}, {"pubmed": 20671051, "text": "methylation of TET2, CBL and CEBPA is infrequent in myeloproliferative neoplasms at diagnosis."}, {"pubmed": 20678218, "text": "Mutations in TET2 occurred with similar frequency in myelodysplastic syndromes and acute myeloid leukemias and associated equally with either ASXL1 or NPM1 mutations."}, {"pubmed": 20678218, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20693430, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20693430, "text": "Seventy-one TET2 mutations, with a relative mutation abundance (RMA) >/= 10%, were identified in 39 of 320 (12%) myelodysplastic syndrome and 16 of 35 (46%) chronic myelomonocytic leukemia patients (P < .001)."}, {"pubmed": 20880116, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21042320, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21042320, "text": "novel TET2 mutations in 3.8% of pediatric AML."}, {"pubmed": 21057493, "text": "disruption of TET2 enzymatic activity favours myeloid tumorigenesis"}, {"pubmed": 21087791, "text": "TET2 deletions are associated with chronic myelomonocytic leukemia."}, {"pubmed": 21130701, "text": "Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation."}, {"pubmed": 21173100, "text": "JAK2 GGCC haplotype and germline mutations in the TET2 gene in patients with familial myeloproliferative neoplasms may cause an increase in overall carcinogenesis."}, {"pubmed": 21251613, "text": "The oncometabolite 2-hydroxyglutarate is a competitive inhibitor of multiple alpha-ketoglutarate-dependent dioxygenases, including histone demethylases, prolyl hydroxylases, and the TET family of 5-methlycytosine hydroxylases."}, {"pubmed": 21273266, "text": "Data showed that in vitro the concomitant presence of JAK2(V617F) and TET2 mutations favors clonal polycythemia vera erythroid progenitors in contrast with non-TET2 mutated progenitors."}, {"pubmed": 21275969, "text": "determination of TET2 mutational status in blastic plasmacytoid dendritic cell neoplasms(BPDCN); BPDCN belongs to the wide spectrum of haematological neoplasms that display TET2 mutations; relevance of TET2 mutation remains undetermined in this disease"}, {"pubmed": 21307773, "text": "Studies indicate that additional mutations in genes which appear to affect the epigenome of MPN patients have been discovered including mutations in TET2, IDH1/ 2, EZH2, and ASXL1."}, {"pubmed": 21310937, "text": "Loss of the TET2 hydroxylase activity in cells homozygous for TET2 mutations does not appear to increase their competitive advantage, suggesting that the TET2 hydroxylase activity is tightly regulated."}, {"pubmed": 21339759, "text": "Mutations in the TET2 gene is associated with chronic myelomonocytic leukemia."}, {"pubmed": 21343549, "text": "TET2 mutations improve the European LeukemiaNet molecular-risk classification in primary cytogenetically normal-acute myeloid leukemia because of their adverse prognostic impact in an otherwise favorable-risk patient subset."}, {"pubmed": 21346257, "text": "TET2 mutation is asssociated with chronic myelogenous leukemia."}, {"pubmed": 21494260, "text": "15 TET2 mutations were sequenced from 13 patients with myelodyplastic syndrome or acute myeloid leukemia: 9 frameshift premature STOP codons, 3 nonsense & 3 missense mutations in the 1st conserved domain. They had a good response to AZA."}, {"pubmed": 21508122, "text": "TET2 mutations did not influence the complete remission rate or overall survival."}, {"pubmed": 21625234, "text": "TET2 mutations and 5-hydroxymethylcytosine levels in secondary acute myeloid leukemia"}, {"pubmed": 21690245, "text": "Results suggest that TET2 promoter methylation, but not TET2 mutation, may be an alternative mechanism of pathogenesis in a small fraction of low-grade diffuse gliomas lacking IDH1/2 mutations."}, {"pubmed": 21723200, "text": "Tet2 haploinsufficiency contributes to hematopoietic transformation in vivo."}, {"pubmed": 21723201, "text": "Impairment of TET2 function or/and expression predisposes to the development of hematological malignancies."}, {"pubmed": 21729597, "text": "TET2 gene mutation is more prevalent in older acute myeloid leukemia patients and has a certain correlation with clinical characteristics and outcome."}, {"pubmed": 21734233, "text": "TET2 disruption affects 5-hmC levels in human myeloid cells and participates in the pathogenesis of myeloid malignancies through the disturbance of myeloid differentiation."}, {"pubmed": 21760590, "text": "TET2 mutation is associated with myelodysplastic syndromes."}, {"pubmed": 21794915, "text": "Decreased TET2 gene expression is associated with chronic myeloid leukemia progression."}, {"pubmed": 21828143, "text": "TET2 mutation is associated with poor prognosis in acute myeloid leukemia patients with intermediate-risk cytogenetics, especially when it is combined with other adverse molecular markers."}, {"pubmed": 21904853, "text": "Data show that TET2 and ASXL1 pathogenic mutations are found in 8% of myeloproliferative neoplasms lacking JAK2 and MPL mutations, whereas IDH1, IDH2, and c-CBL mutations are not detected in this subset of patients."}, {"pubmed": 21920603, "text": "Frequent co-occurrence of 4q24/TET2 and 5q and/or 7q deletions."}, {"pubmed": 22017486, "text": "TET2 haploinsufficiency recurrently occurs in myeloid malignancies, frequently combined with TET2 mutations on the remaining allele."}, {"pubmed": 22080757, "text": "TET2 mutations shows a distinct distribution pattern in de novo acute myeloid leukemia and chronic myelomonocytic leukemia."}, {"pubmed": 22116554, "text": "negative effect of TET2 mutation on EFS was particularly observed in patients over 65 years as well as in patients of the European LeukemiaNet favorable-risk subgroup, that is, patients harboring mutated CEBPA and/or mutated NPM1 without FLT3-ITD"}, {"pubmed": 22200996, "text": "In both mouse and human cells, TET2 inactivation leads to a dramatic deregulation of hematopoiesis that ultimately triggers blood malignancies."}, {"pubmed": 22216861, "text": "Our data extend the common mutations linking T-cell lymphoma and myeloid cancer. They also suggest an oncogenic cooperation between TET2 and DNMT3A mutations."}, {"pubmed": 22328940, "text": "The results demonstrate the presence of aberrant DNA methylation in CMML and identifies TET2 mutant CMML as a biologically distinct disease subtype with a different epigenetic profile."}, {"pubmed": 22395470, "text": "TET2 mutations affect global methylation in chronic myelomonocytic leukemia."}, {"pubmed": 22430270, "text": "TET2(mut) were identified in 7.6% of younger adult patients with acute myeloid leukemia and did not impact the response to therapy and survival."}, {"pubmed": 22489043, "text": "TET2 mutations were present in 18 of 149 myeloproliferative neoplasm patients (12%) and somewhat more evenly distributed across subtypes than ASXL1 mutations."}, {"pubmed": 22569366, "text": "Hydroxylation of 5-methylcytosine by TET2 maintains the active state of the HOXA cluster."}, {"pubmed": 22760778, "text": "TET2 mutations were associated with advanced-stage disease, thrombocytopenia, high International Prognostic Index scores, and a shorter progression-free survival."}, {"pubmed": 22905207, "text": "TET2, DNMT3A, CBL and ASXL1 mutations are present in mastocytosis and these mutations may affect prognosis, as demonstrated by worse OS in mutated patients"}, {"pubmed": 22943828, "text": "The mRNA expression of TET2 in CD(3)(+) T cells of myelodysplastic syndrome patients was decreased while the mRNA expression of DLK1 was increased."}, {"pubmed": 22981865, "text": "Our observations indicate that Tet2 helps CEBPalpha rapidly derepress myeloid genes during the conversion of pre-B cells into macrophages."}, {"pubmed": 23001125, "text": "TET2 mutations are specific to individuals with clonal hematopoiesis"}, {"pubmed": 23009937, "text": "TET2 mutations are associated with the pathogenesis of myeloproliferative neoplasms."}, {"pubmed": 23065512, "text": "Data show that myelodysplastic chronic myelomonocytic leukemias are characterized by mutations in transcription/epigenetic regulators ASXL1, RUNX1, TET2 and SRSF2."}, {"pubmed": 23074272, "text": "Data show that in contrast to the oncogenic KITD816V, TET2 mutation statistically associates with aggressive forms of the disease."}, {"pubmed": 23099237, "text": "TET2, ASXL1 and EZH2 mutations in Chinese with myelodysplastic syndromes."}, {"pubmed": 23135354, "text": "epigenetics-modifying gene (DNMT3a, TET2 and IDH1/2) mutations had no change between diagnosis and relapse samples, and may become minimal residual disease marker"}, {"pubmed": 23222540, "text": "The double epigenetic modifications on both DNA and histones by TET2 and OGT coordinate together for the regulation of gene transcription."}, {"pubmed": 23365461, "text": "Data indicate there were two patients carried ASXL1 mutations, both with t(8;21), 2 had DNMT3A mutations, 2 had IDH1 mutations, 1 had IDH2 mutation, and 3 had TET2 mutations."}, {"pubmed": 23521373, "text": "A large percentage of CEBPA double-mutated acute myeloid leukaemia cases harboured additional alterations in other molecular markers and that at least GATA2 and TET2 alterations demonstrated a substantial impact on prognosis in these patients."}, {"pubmed": 23563267, "text": "IDAX expression results in caspase activation and TET2 protein downregulation, in a manner that depends on DNA binding through the IDAX CXXC domain, suggesting that IDAX recruits TET2 to DNA before degradation"}, {"pubmed": 23705593, "text": "Results provide definite evidence that TET2 mediates conversion of 5-methylcytosine to 5-hydroxymethylcytosine in monocytes."}, {"pubmed": 23781511, "text": "TET2 mutations occur in both JAK2 V617F-positive and -negative myeloproliferative neoplasms."}, {"pubmed": 23820384, "text": "MiR-29a mimics decrease the levels of Tet1, Tet2, and Tet3; miR-29a inhibition increases all three Tets in human dermal fibroblasts."}, {"pubmed": 23827711, "text": "Low TET2 expression is associated with myelodysplastic syndrome."}, {"pubmed": 23831920, "text": "TET2 mutations cause aberrant DNA methylation in diffuse large B-cell lymphoma."}, {"pubmed": 23863747, "text": "The transcription factor EBF1 is an interaction partner for TET2, suggesting a sequence-specific mechanism for regulating DNA methylation."}, {"pubmed": 23940084, "text": "findings show blastic plasmacytoid dendritic cell neoplasm in the bone marrow has a characteristic immunoprofile and appears to be commonly associated with myelodysplastic features and a high frequency of TET2 mutations in the absence of other mutations commonly observed in AML"}, {"pubmed": 23996483, "text": "TET2 and IDH mutations did not have any significant impact on OS, while TET2 mutations were significantly associated with progression to sAML."}, {"pubmed": 24028770, "text": "PU.1- targeted genes undergo Tet2-coupled demethylation and DNMT3b-mediated methylation in monocyte-to-osteoclast differentiation."}, {"pubmed": 24077167, "text": "We identify TET2 as a novel and necessary master epigenetic regulator of smooth muscle cell differentiation."}, {"pubmed": 24120864, "text": "Several TET2-targeting miRNAs, including miR-125b, miR-29b, miR-29c, miR-101, and miR-7, are preferentially overexpressed in TET2-wild-type acute myeloid leukemia."}, {"pubmed": 24122999, "text": "A significant decrease in 5-hydroxymethylcytosine and TET2 expression was found in oral squamous cell carcinoma compared to healthy oral epithelium."}, {"pubmed": 24218139, "text": "In a patient cohort of myelodysplastic disorders, EZH2 mutations were found and often coincided with tet methylcytosine dioxygenase 2 (TET2) mutations."}, {"pubmed": 24220273, "text": "data indicate that the mechanism of IL-6 and TGF-beta1 production in renal tissue of Thy-1N rats is associated with sublytic C5b-9 up-regulated p300 and p300-mediated C/EBPbeta acetylation"}, {"pubmed": 24315485, "text": "Study presents the crystal structure of human TET2 bound to methylated DNA at 2.02 A resolution. The structure shows that two zinc fingers bring the Cys-rich and DSBH domains together to form a compact catalytic domain."}, {"pubmed": 24394411, "text": "Although TET1 and TET2 also interact with and can be O-GlcNAcylated by OGT, neither their subcellular localization nor their enzymatic activity are affected by OGT."}, {"pubmed": 24413737, "text": "Impaired RHOA function in cooperation with preceding loss of TET2 function contributes to angioimmunoblastic T cell lymphoma-specific pathogenesis."}, {"pubmed": 24433485, "text": "Study assessed the role of TET2 mutations in the diagnosis of different MPN subtypes when JAK2 and MPL mutations are missing."}, {"pubmed": 24465546, "text": "ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases."}, {"pubmed": 24524305, "text": "These findings indicate that TET2 mutations have an adverse impact on prognosis and may help to justify risk-adapted therapeutic strategies for patients with AML."}, {"pubmed": 24693539, "text": "Overexpression of TET2 in chronic lymphocytic leukemia seems to be unrelated to the presence of genomic TET2 variations."}, {"pubmed": 24697267, "text": "The data indicates that leukaemia-associated TET2 mutations lead to complete or partial loss of TET2 function."}, {"pubmed": 24723429, "text": "our work suggests that TET2 is involved in different stages of human embryonic development, including induction of the mesoderm and hematopoietic differentiation."}, {"pubmed": 24735979, "text": "TET2 and DNMT1 expression is significantly down-regulated in MS."}, {"pubmed": 24795056, "text": "The present study analyzed the TET2 gene in 99 myeloproliferative neoplasms patients."}, {"pubmed": 24832084, "text": "TET2 is a susceptibility locus for endometrial cancer. [Meta-anaysis]"}, {"pubmed": 24859829, "text": "TET2 gene mutation was identified as an unfavorable prognostic factor in cytogenetically normal acute myeloid leukemia patients (cn-AML) with the NPM1+/FLT3-internal tandem duplications - mutations."}, {"pubmed": 24898826, "text": "TET2 mutations were identified as subclones in four of the six investigated patients by deep sequencing."}, {"pubmed": 24915579, "text": "These results indicate that IGF2BP1 and TET1/2 contribute to the stemness of MSCs, at least regarding their proliferative potential."}, {"pubmed": 24958354, "text": "TET1 depletion yields widespread reduction of 5hmC, while depletion of TET2 and TET3 reduces 5hmC at a subset of TET1 targets suggesting functional co-dependence."}, {"pubmed": 24980573, "text": "TET2 genetic variation and mutation in melanoma. [Meta-analysis]"}, {"pubmed": 24994606, "text": "TET2 mutants do not suppress the function of the wild-type protein and hence do not show dominant negative traits. Both loss-of-function mutations and low expression of TET2 are markers of poor prognosis in AML."}, {"pubmed": 25040794, "text": "TET2 is a critical regulator for hematopoietic stem cell homeostasis whose functional impairment leads to hematological malignancies. [Review]"}, {"pubmed": 25082530, "text": "The described are hematopoietic clonal dominance, stem cell mutations (in TET2, DNMT3A), and evolutionary pattern of JAK2V617F allele burden in polycythemia vera."}, {"pubmed": 25200248, "text": "Defective TET2 expression plays a role in the MDS pathophysiology and predicts survival outcomes in this disease."}, {"pubmed": 25224413, "text": "Data indicate that tet oncogene family member 2 protein (TET2) mutations can identify patients more likely to respond to hypomethylating agents (HMAs)."}, {"pubmed": 25381129, "text": "TET2 mutations were associated with acute myeloid leukemia."}, {"pubmed": 25482556, "text": "WT1 physically interacts with TET2 and TET3, and WT1 loss of function results in a similar hematopoietic differentiation phenotype as observed with TET2 deficiency."}, {"pubmed": 25503193, "text": "DNA demethylation modifications regulate Oxidized low-density lipoprotein treated THP-1 macrophages autophagy and TET2 might be a novel regulator."}, {"pubmed": 25557551, "text": "VprBP, but not DDB1, directly binds to TET2-catalytic domain."}, {"pubmed": 25568311, "text": "TET1, TET2, and TET3 are highly phosphorylated."}, {"pubmed": 25596262, "text": "study identified TET2 and ASXL1 mutations in Chinese patients with aplastic anemia"}, {"pubmed": 25601757, "text": "TET2 suppresses leukemia cell proliferation and colony formation in a manner dependent on WT1."}, {"pubmed": 25671252, "text": "The order in which JAK2 and TET2 mutations were acquired influenced clinical features, the response to targeted therapy, the biology of stem and progenitor cells, and clonal evolution in patients with myeloproliferative neoplasms."}, {"pubmed": 25687841, "text": "Double somatic mosaic mutations in TET2 (and DNMT3A) were identified in a patient with peripheral T cell lymphoma."}, {"pubmed": 25695618, "text": "This exploratory study reports two plausible loci associated with systolic blood pressure response to hydrochlorothiazide: TET2, an aldosterone-responsive mediator of alphaENaC gene transcription; and CSMD1, previously described as associated with hypertension in a case-control study."}, {"pubmed": 25827305, "text": "The expression of 5-hmC, 5-mC, and TET2 correlated with pathologic stage, tumor grading, lymph node metastasis, and vascular thrombosis."}, {"pubmed": 25853800, "text": "we have potentially eliminated a maintenance role for TET2 in keeping the target promoters free of DNA methylation in colon cancer, this does not preclude the TETs from having an initiating function that marks genes for activation during early development"}, {"pubmed": 25961778, "text": "Mutation in TET2 or TP53 predicts poor survival in patients with myelodysplastic syndrome receiving hypomethylating treatment or stem cell transplantation."}, {"pubmed": 25972343, "text": "Leukemia-associated TET2 mutations affect DNA methylation at non-CpG Island regions containing hematopoietic-specific enhancers and transcription factor-binding sites."}, {"pubmed": 26045292, "text": "Adverse prognostic effect of homozygous TET2 mutation on the relapse risk of acute myeloid leukemia in patients of normal karyotype."}, {"pubmed": 26075789, "text": "O-GlcNAcylation of the transcription regulators Host Cell Factor-1 (HCF-1) and Ten-Eleven Translocation protein 2 (TET2) could be readily observed. Our study raises questions on the occurrence and abundance of O-GlcNAcylation as a histone modification"}, {"pubmed": 26093090, "text": "5-methylcytosine (5-hmC) expression is decreased in esophageal squamous cell carcinoma tissues, and is associated with TET2 expression level; TET2 reduction and subsequent 5-hmC loss might affect ESCC development"}, {"pubmed": 26099018, "text": "Role of TET2 and TET2-interacting proteins in normal hematopoiesis and hematological malignancies"}, {"pubmed": 26126966, "text": "present novel evidence that the TET2 SNP rs2454206 (I1762V) is a prognostic marker for outcome in pediatric acute myeloid leukemia"}, {"pubmed": 26277372, "text": "The existence of a regulatory loop between microRNA-22 and TET2 may play a role in Myelodysplastic syndrome pathogenesis"}, {"pubmed": 26287468, "text": "Tet2 selectively mediates active repression of interleukin-6 (IL-6) transcription during inflammation resolution in innate myeloid cells, including dendritic cells and macrophages"}, {"pubmed": 26356709, "text": "TET2 locus might be involved in the modulation of the liver PPARGC1A methylation/demethylation balance, that would influence the development of Type 2 diabetes."}, {"pubmed": 26404510, "text": "A member of the ten-eleven translocation (TET) proteins, which catalyse the oxidation of methylated cytosine (5-mC) to 5-hmC, TET2, is repressed by androgens in prostate cancer."}, {"pubmed": 26414667, "text": "The prevalence of TET2 mutations in children with acute myeloid leukemia (AML) compared with adults with AML was lower and less complex. Patients with polymorphism I1762V had an increased 10-year survival rate compared with patients without I1762V."}, {"pubmed": 26524525, "text": "crystal structures of TET2-5hmC-DNA and TET2-5fC-DNA complexes at 1.80 A and 1.97 A resolution, respectively"}, {"pubmed": 26551667, "text": "Mutations in TET2 gene is associated with cutaneous T cell lymphoma and Sezary syndrome."}, {"pubmed": 26562302, "text": "Data show that tet methylcytosine dioxygenase 2 TET2, isocitrate dehydrogenases 1/2 IDH1/IDH2, serine/arginine-rich splicing factor 2 SRSF2, splicing factor 3b subunit 1 SF3B1, and ras proteins (KRAS/NRAS) are not conserved in dog mast Cell tumors."}, {"pubmed": 26568194, "text": "Low levels of tet2-DMC (Differentially Methylated CpG) define a subgroup of AML that is highly curable and cannot be identified solely by genetic and cytogenetic analyses."}, {"pubmed": 26617797, "text": "CD34(+) cells lowering expression of TET2 may play an oncogenic role on myeloid tumor and CD3(+) T cells of myelodysplastic syndrome patients may be derived from the malignant clone."}, {"pubmed": 26663912, "text": "5-hydroxymethylation of the EBV genome regulates the latent to lytic switch."}, {"pubmed": 26711177, "text": "Here, the authors reveal the methylcytosine dioxygenases TET1 and TET2 as active regulators of CTCF-mediated alternative splicing through conversion of 5-methylcytosine to its oxidation derivatives."}, {"pubmed": 26763362, "text": "TET2 mutation occurred in a number of ATLL patients and was likely involved in their leukemogenesis."}, {"pubmed": 26769901, "text": "MBD3L2 is more effective than MBD3 in promoting Tet2 enzymatic activity through strengthening the binding affinity between Tet2 and the methylated DNA target."}, {"pubmed": 26771811, "text": "We confirm the negative prognostic impact imparted by ASXL1 mutations and suggest a favorable impact from TET2 mutations in the absence of ASXL1 mutations."}, {"pubmed": 26825711, "text": "Among 864 Dutch persons between 80 and 105.8 years of age, DNA sequence analysis of TET2 confirmed a high incidence of somatic mutations but no effect on 10-year survival."}, {"pubmed": 26843622, "text": "this study found a novel hereditary susceptible factor-TET2 rs3733609 C/T variant for the development of Myeloproliferative neoplasms, suggesting the variant may be partially responsible for the pathogenesis and accumulation of Myeloproliferative neoplasms."}, {"pubmed": 26880370, "text": "inactivation of MLL3 and TET2 may play an important role in the tumorigenesis process of HTLV-I-induced acute adult T-cell leukemia."}, {"pubmed": 26917261, "text": "TET1, TET2, and TET3 genes are downregulated in endometriosis."}, {"pubmed": 26921880, "text": "The levels of alpha-KG, TET2 and MMP-9 were significantly increased in diabetic wound compared with nondiabetic wound"}, {"pubmed": 26980223, "text": "review examines mutant IDH1/2 and TET2 enzymes in the context of responses to DNA damage and their potential involvement in age-related genomic instability."}, {"pubmed": 26984174, "text": "TET2 expression is reduced in myelodysplatic syndrome/acute myeloid leukemia patients, independently of mutational status."}, {"pubmed": 27005421, "text": "we show that the TET2 expression and 5hmC abundance are significantly altered in the umbilical veins of GDM and preeclampsia.The alteration of TET expression, 5hmC levels and 5hmC-mediated transposon activity was further confirmed using established hypoxia cell culture model, which could be rescued by vitamin C, a known activator of TET proteins"}, {"pubmed": 27027260, "text": "ANRIL knockdown blocks the effects of TET2 on gastric cancer cell proliferation and colony formation."}, {"pubmed": 27102770, "text": "Our findings provide evidence suggesting that nestin regulation is negatively controlled epigenetically by TET2 in melanoma"}, {"pubmed": 27288448, "text": "this study demonstrates the critical role of TET proteins in regulating the crosstalk between two key epigenetic mechanisms."}, {"pubmed": 27289557, "text": "The data suggest that TET2 activity and the levels of 5-hydroxymethylcytosine and its derivatives should be tightly controlled to avoid genetic and chromosomal instabilities."}, {"pubmed": 27384850, "text": "TET2 mutations are likely to be acquired at the common myeloid/lymphoid progenitor levels"}, {"pubmed": 27391574, "text": "Multivariate analysis showed that KIT-AL and TET2 mutations were associated with inferior LFS, whereas age 40 years and marrow blast 70% were associated with inferior OS."}, {"pubmed": 27418193, "text": "Our results confirmed that TET2 is frequently mutated in Taiwanese patients with chronic myelomonocytic leukemia"}, {"pubmed": 27486019, "text": "TET2 in African Americans was associated with aggressive prostate cancer, with 24.4% of cases harboring a rare deleterious variant compared with 9.6% of controls"}, {"pubmed": 27497531, "text": "identified a novel case of a donor-derived myelodysplastic syndrome in an HSCT recipient that is consistent with clonal evolution of TET2-mutated clonal hematopoiesis of indeterminate potential (CHIP)"}, {"pubmed": 27644645, "text": "Hypermethylation and downregulation of TET2 gene may play a role in predisposition to childhood ALL."}, {"pubmed": 27729528, "text": "Here we report that retinoic acid (RA) or retinol (vitamin A) and ascorbate (vitamin C) act as modulators of TET levels and activity. RA or retinol enhances 5hmC production in naive embryonic stem cells by activation of TET2 and TET3 transcription, whereas ascorbate potentiates TET activity and 5hmC production through enhanced Fe(2+) recycling, and not as a cofactor as reported previously"}, {"pubmed": 27761930, "text": "Concurrent STAT3, DNMT3A, and TET2 mutations in T-LGL leukemia with molecularly distinct clonal hematopoiesis of indeterminate potential"}, {"pubmed": 27819678, "text": "Endogenous TET2 bound the androgen receptor (AR) and AR-coactivator proteins in LNCaP cell extracts, and TET2 KD increases prostate-specific antigen (KLK3/PSA) expression."}, {"pubmed": 27829228, "text": "TET2 functions as a resistance factor against DNA methylation in gastric epithelial cells and repression of TET2 contributes to DNA methylation acquisition during Epstein Barr virus infection."}, {"pubmed": 27848178, "text": "This article focuses mainly on the biological aspects of TET2 mutations, followed by a brief review of recent progress in our understanding of their epigenetic aspects in hematologic malignancies. [review]"}, {"pubmed": 27852070, "text": "DNMT3A senses the TGF-beta signal and silences TET2 and TET3 promoters to induce the epithelial-mesenchymal transition-like process and metastasis in melanoma."}, {"pubmed": 27881874, "text": "Mutation in the TET2 gene is associated with acute myeloid leukemia patients with lympho-myeloid clonal hematopoiesis."}, {"pubmed": 27918559, "text": "The TET2 active site is shaped to enable higher-order oxidation and provide the first TET variants that could be used to probe the biological functions of 5-methylcytosine separately from 5-formylcytosine and5-carboxylcytosine."}, {"pubmed": 27921272, "text": "Deregulated BCL6 expression caused by hypermethylation and TET2 mutations may result in skewed follicular helper T cell differentiation and eventually contribute to angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma development in patients"}, {"pubmed": 27997762, "text": "This result suggests that TET2(P1962T) mutation in association with germline RUNX1(R174Q) mutation leads to amplification of a haematopoietic clone susceptible to acquire other transforming alterations"}, {"pubmed": 28003489, "text": "TET2 is turned off in normal and malignant germinal center (GC) B cells but expressed in other B cell types. Thus, restricted TET2 expression in GC cells may promote type I Epstein-Barr virus latency."}, {"pubmed": 28077417, "text": "indicate that AID and TET2 share common effects on myeloid and erythroid lineage differentiation, however, their role is nonredundant in regulating HSC self-renewal and in myeloid transformation."}, {"pubmed": 28107650, "text": "TET2 removes aberrant DNA methylation during oxidative stress through interaction with DNA methyltransferases in a \"Yin-Yang\" complex targeted to chromatin and enhanced by p300 mediated TET2 acetylation."}, {"pubmed": 28130413, "text": "Data show that tet oncogene family member 2 (TET2) cysteine-rich (CR) domain mutations disrupt the recognition of histone H3 lysine 36 (H3K36) methylation, its cellular localization, and enzyme activity."}, {"pubmed": 28167452, "text": "TET2E2S and FLT3-ITD, but not age or NPM1 mutation status were independent prognostic factors for DFS and event-free survival (EFS) in cytogenetically normal acute myelogenous leukemia , while TET2E2S was the sole prognostic factor that we identified for overall survival (OS)."}, {"pubmed": 28167661, "text": "findings have identified distinct roles for TET2 and TET3 in human erythropoiesis, and provide new insights into their role in regulating human erythroid differentiation at distinct stages of development."}, {"pubmed": 28218476, "text": "Because the DNA hypomethylation might be a result of TET dioxygenase activity, the study examined expression of TET1-3 enzymes and the level of their product, 5-hydroxymethylcytosine (5hmC), in a panel of histologically characterized seminomas and non-seminomatous germ cell tumors. The study found highly increased expression of TET1 dioxygenase in most seminomas and strong TET1 staining in seminoma cells."}, {"pubmed": 28218607, "text": "TET2, ASXL1, IDH1, and IDH2 Single Nucleotide Polymorphisms in Turkish Patients with Chronic Myeloproliferative Neoplasms."}, {"pubmed": 28252217, "text": "Therefore, chemical hypoxia not only causes overexpression of TET1 and TET2 but also could gradually do promoter demethylation of same genes"}, {"pubmed": 28331128, "text": "TET2 mutation occurred in some populations of DLBCL patients and was likely involved in the pathogenesis of their malignancies"}, {"pubmed": 28337768, "text": "TET2-mutated haematopoietic precursor cells in Angioimmunoblastic T-cell lymphomas (AITLs) patients not only give rise to the T-cell lymphoma but also generate a large population of mutated mature B cells."}, {"pubmed": 28349832, "text": "We found that TET1 and TET2 messenger RNA expression was lower and TET3 was higher in cancers compared to normal tissues. Positive correlation between 5-hmC and the relative expression of TET1 and TET2 was found, but no correlation was observed in the case of TET3."}, {"pubmed": 28407691, "text": "hypermethylation of the MEG3 promoter in AML may result from decreased TET2 activity. These data provide insight into the molecular mechanisms underlying AML development and progression"}, {"pubmed": 28440315, "text": "TET2-mutated myeloid malignancy patients have significantly more mutational events than patients with wild-type TET2, suggesting a novel TET2 loss-mediated mechanism of hematological malignancy pathogenesis."}, {"pubmed": 28452984, "text": "Patients with mutations 6 showed higher rate of achieving major molecular response than those<6 (P=0.0381). Mutations in epigenetic regulator, ASXL1, TET2, TET3, KDM1A and MSH6 were found in 25% of patients. TET2 or TET3, AKT1 and RUNX1 were mutated in one patient each. ASXL1 was mutated within exon 12 in three cases"}, {"pubmed": 28521175, "text": "Our findings suggest that TET2 mutations have no prognosis impact on overall survival of patients with myelodysplastic syndromes"}, {"pubmed": 28642344, "text": "Data suggest that deregulated expression of TET2 by DNA hypermethylation may contribute to the aberrantly low level of 5hmC in parathyroid carcinoma and further that TET2 plays a cell growth and cell migratory regulatory role and may constitute a parathyroid tumor suppressor gene."}, {"pubmed": 28655780, "text": "Somatic mutations driving clonal hematopoiesis occur mainly in DNMT3A and TET2 and have no significant impact on hematological phenotypes.  There is a familial predisposition to acquire TET2 mutation."}, {"pubmed": 28691928, "text": "TET2 and RhoA mutations cooperatively disrupt T cell homeostasis"}, {"pubmed": 28731140, "text": "The results of the present study demonstrated that the genes cryptochrome circadian clock 1, zinc finger protein (ZNF) interacting with K protein 1, ZNF134, ZNF256 and ZNF615, which were hypermethylated and downregulated in Diffuse large B-cell lymphoma (DLBCL) patients with TET2 mutations, were the key genes in the association between DLBCL and TET mutations."}, {"pubmed": 28813659, "text": "this study shows that Tet2 expression is increased in intratumoral myeloid cells in melanoma patients"}, {"pubmed": 28826859, "text": "Tet methylcytosine dioxygenase 2 (TET2) mutations can be detected in human MPhis cultured from MDS/CMML patient samples."}, {"pubmed": 28923852, "text": "Overexpression of the wild-type TET1/2/3 3'UTR caused a significant increase in EZH2 expression and tumor growth, whereas the mutation in miR-26-binding sites abolished this effect."}, {"pubmed": 28973458, "text": "TET2- and TDG-mediated changes are required for the acquisition of distinct histone modifications in divergent terminal differentiation of myeloid cells."}, {"pubmed": 28992762, "text": "alterations in DNMT3A and TET2 may be associated with acute myeloid leukemia prognosis"}, {"pubmed": 29195897, "text": "this is the first evidence to suggest that TET2 mutations promote clonal dominance with aging by conferring TNFalpha resistance to sensitive bone marrow progenitors while also propagating such an inflammatory environment."}, {"pubmed": 29219176, "text": "The findings indicated that down-regulation of TET2 expression was a common event and acted as a prognostic and predictive biomarker in cytogenetically normal acute myeloid leukemia patients."}, {"pubmed": 29227812, "text": "mutations in the epigenetic regulators TET2 and DNMT3A corresponded to high ARG1 expression and activity. These findings suggest ARG1 is a biomarker of immune dysregulation in early MDS and CMML"}, {"pubmed": 29275866, "text": "Tet2/Nras double-mutant leukemia showed preferential sensitivity to MAPK kinase (MEK) inhibition in both mouse model and patient samples"}, {"pubmed": 29331390, "text": "the dysregulation of TET2/E-cadherin/beta-catenin regulatory loop is a critical oncogenic event in HCC progression"}, {"pubmed": 29331774, "text": "low-dose Vitamin C and decitabine has a synergistic efficacy on proliferation, apoptosis, TET2 expression and activity, compared to drug-alone treatment in HL60 and NB4 cell lines in vitro."}, {"pubmed": 29411884, "text": "Blastic plasmacytoid dendritic cell neoplasm with unusual morphology, MYC rearrangement and TET2 and DNMT3A mutations."}, {"pubmed": 29483655, "text": "PSPC1 and TET2 contribute to ERVL and ERVL-associated gene regulation by both transcriptional repression via histone deacetylases and post-transcriptional destabilization of RNAs through 5hmC modification."}, {"pubmed": 29515232, "text": "TET2 mediates DNA demethylation of the IL-6 promoter in osteosarcoma (OS) primary tumor cells. TET2 is essential for OS cell metastasis. Its knockdown inhibits demethylation of IL-6 promoter and upregulates IL-6 expression in xenograft tumors decreasing tumor metastasis. These findings suggest that TET2-dependent IL-6 induction enables acquisition of aggressive phenotypes in OS cells via tumor microenvironment."}, {"pubmed": 29567563, "text": "The anti-inflammatory actions of Vicenin-2 are associated not only with increased IL-10 and IL-1Ra expression, but also with TET-2 up-regulation."}, {"pubmed": 29653065, "text": "Studies indicate that TET methylcytosine dioxygenase 2 (TET2) plays an important role in preventing atherosclerosis by repressing vascular smooth muscle cell (VSMC) phenotype transformation, protecting endothelial cells (ECs) from damage and dysfunction, and inhibiting inflammation [Review]."}, {"pubmed": 29654353, "text": "TET2-dependent DNA demethylation might play an important role in dental pulp inflammation as an epigenetic regulator."}, {"pubmed": 29664232, "text": "Our data demonstrate that TET2 SNP rs2454206AG/GG correlates with improved overall survival and event-free survival in childhood acute myeloid leukemia featuring intermediate-risk cytogenetics. No difference in TET2 expression levels in acute myeloid leukemia with TET2 SNP rs2454206(AA) and TET2 SNP rs2454206(AG/GG) was detected, indicating that TET2 SNP rs2454206 status does not affect TET2 expression in pediatric AML."}, {"pubmed": 29705354, "text": "TET2 plays an important role in the pathogenesis of diabetic nephropathy by activating TGFbeta1 expression through demethylation of CpG islands in the TGFbeta1 regulatory region"}, {"pubmed": 29735542, "text": "Promyeloctic leukemia protein recruits TET2, regulating DNA modification and cell proliferation in response to chemotherapeutic agents."}, {"pubmed": 29764839, "text": "we demonstrated that DNMT3A and TET2, the 2 most frequently mutated genes in CHIP, have distinctive patterns of hematopoietic cell involvement and a different myeloid proliferation bias."}, {"pubmed": 29773648, "text": "a critical role of TET2 in regulating trophoblast cell migration through demethylation at the MMP9 promoter"}, {"pubmed": 29795413, "text": "Mutations in TET2 gene and its founder defect induces phenotypic shifts toward dysplasia, myeloproliferation, or progression to acute myeloid leukemia."}, {"pubmed": 29883611, "text": "HIV-1 Vpr degrades TET2 by CRL4 E3 ligase to sustain IL-6 expression to enhance viral replication and disease progression."}, {"pubmed": 29944140, "text": "We identified TET2 epigenetic enzyme as a key factor controlling slow-cycling cancer cell (SCCC) numbers, survival, and tumor recurrence. 5-Hydroxymethylcytosine, generated by TET2 enzymatic activity, labeled the SCCC genome in carcinomas and was a predictive biomarker of relapse and survival in cancer patients."}, {"pubmed": 30013992, "text": "Authors have demonstrated that excessive amounts of STAT5 may bind more TET2 to the FOXP3-TSDR and upregulate FOXP3 expression via DNA demethylation. Study improved the mechanism of FOXP3-TSDR hypomethylation in tumor-infiltrating CD4(+) T cells of CRC patients."}, {"pubmed": 30022161, "text": "findings define a novel 'phospho-switch' that regulates TET2 stability and a regulatory pathway that links glucose and AMPK to TET2 and 5hmC, which connects diabetes to cancer; data also unravel an epigenetic pathway by which metformin mediates tumour suppression; thus, this study presents a new model for how a pernicious environment can directly reprogram the epigenome towards an oncogenic state"}, {"pubmed": 30045709, "text": "Analyzed involvement of 5-hydroxymethylcytosine (5hmC), tet methylcytosine dioxygenase 1 (TET1) and tet methylcytosine dioxygenase 2 (TET2) in small intestinal neuroendocrine tumors."}, {"pubmed": 30074219, "text": "The expression of TET1, TET2, and TET3 was lower in the villi in early pregnancy loss group than in normal pregnancy group"}, {"pubmed": 30130982, "text": "abnormal expression in eutopic endometrium from infertile women with endometriosis"}, {"pubmed": 30146412, "text": "The results indicate that restoring TET2 function through SIRT1 activation represents a promising means to target Myelodysplastic syndrome (MDS) hematopoietic stem/progenitor cells (HSPCs)."}, {"pubmed": 30152885, "text": "Contrary to previous reports, no association was found between TET2 mutations and hypomethylating agents treatment response in MDS."}, {"pubmed": 30254129, "text": "TET2 deficiency leads initially to stem cell factor (SCF)-dependent hyperproliferation and impaired differentiation of human colony-forming unit-erythroid (CFU-E) cells, which were reversed by a c-Kit inhibitor."}, {"pubmed": 30274972, "text": "Data show that tet oncogene membrane 2 (TET2) is required for exit of the GC, B-cell differentiation, and is a tumor suppressor for mature B cells."}, {"pubmed": 30357811, "text": "The data clearly demonstrate that AID and TET2 co-operation regulates FANCA expression by active demethylation. In addition, compound AID and TET2 blockade and bortezomib treatment induces diffuse large B cell lymphoma cell apoptosis."}, {"pubmed": 30370524, "text": "Which comprises miR-125a-5p and TET2 in VECs."}, {"pubmed": 30390073, "text": "A functional interplay between TET2 and p53 during anti-cancer therapy, establishes the rationale for targeting TET2 to overcome chemotherapy resistance associated with mutant p53 tumors."}, {"pubmed": 30404004, "text": "This study also reveals a TET2-SNIP1-c-MYC pathway in mediating DNA damage response."}, {"pubmed": 30454965, "text": "People with TET rs2454206 G/A genotype and TET2rs12498609 G/C genotypewere related to lower prevalence of myelodysplastic syndromes (MDS). Both SNPs were associated with certain laboratory features in MDS patients"}, {"pubmed": 30566180, "text": "This research's data suggests that somatic mutations in hematopoietic cells, specifically in the most commonly mutated CHIP driver genes TET2 and DNMT3A, may be significantly associated with the progression and poor prognosis of Congestive Heart Failure."}, {"pubmed": 30587503, "text": "TET2 mutation appeared not to have additional effects when combined with SF3B1, and patients with double mutation appeared to have at least as, good as or even better prognosis than patients with isolated mutation."}, {"pubmed": 30606231, "text": "TET2 was directly responsible for 5 hydroxymethylcytosine levels on osteogenic and adipogenic lineage-associated genes."}, {"pubmed": 30709865, "text": "biTET2 (i) did not portend faster progression but rather determined monocytic differentiation, consistent with its prevalence in CMML. Additionally, biTET2 (i) showed lower odds of cytopenias and marrow blasts (>/=5%) and higher odds of myeloid dysplasia and marrow hypercellularity."}, {"pubmed": 30888082, "text": "Data showed that TET2 was downregulated in glioblastoma multiforme (GBM) and was involved in miR-19a-mediated proliferation and metastasis by directly being targeted. Its ectopic overexpression remarkably abrogated the facilitative effect of miR-19a on GBM. These findings indicated that TET2 worked as an anti-oncogene in GBM. Also, the expression of TET2 was positively regulated by AC016405.3."}, {"pubmed": 30890702, "text": "these findings provide insight into the interplay between epigenetic modulators and transcription factor activity in hematological neoplasia, but do not confirm the putative role of TET2 in atherosclerosis."}, {"pubmed": 30917865, "text": "Study identifies seven genes governed by TET2 loss in prostate cancer (PCa) which exhibit an association between their methylation and expression status and measures of PCa progression."}, {"pubmed": 30987683, "text": "Hyperglycemia appeared to promote the mRNA expression of SIRT6, TET2 and TE3, which in turn might cause the dynamic changes of 5mC and 5hmC in white blood cells from type 2 diabetes mellitus patients."}, {"pubmed": 31023266, "text": "TET2 mutation had adverse impacts on survival and treatment response in acute myeloid leukemia patients and will contribute to risk-stratification, prognosis prediction and therapy guidance."}, {"pubmed": 31097631, "text": "Clonal sequence tracking reveals TET2-mutated extranodal NK/T-cell lymphoma disseminated independent of Epstein Barr virus."}, {"pubmed": 31164154, "text": "Data demonstrated that AMPK is a critical regulator of myogenesis, partly through phosphorylating TET2."}, {"pubmed": 31167695, "text": "The methylation level is reduced in the villi of women with unexplained recurrent spontaneous abortion, which may be correlated with up-regulated expression of DNMT1 and DNMT3b and down-regulated expression of TET1 and TET2."}, {"pubmed": 31171909, "text": "In our microarray study, the mRNA levels of DNMT1 and DNMT3A were significantly lower while TET2 was higher in acute-stage Kawasaki disease patients compared to the healthy controls. Through PCR validation, we observed that the expression of DNMT1 and TET2 are consistent with the Transcriptome Array 2.0 results."}, {"pubmed": 31187595, "text": "We have identified 38 TET2 allelic variants in the studied patients, including two frequent SNPs: p.G355D (10 cases) and p.I1762V (28 cases). Four of the detected mutations are reported here for the first time: c.122C>T (p.P41L), c.4535C>G (p.A1512G), c.4760A>G (p.D1587G), and c.5087A>T (p.Y1696F)."}, {"pubmed": 31266538, "text": "Finding that MYC directly deregulates the expression of TET1 and TET2 in T-ALL provides novel evidence that MYC controls DNA (hydroxy)methylation in a genome-wide fashion. It reveals a coordinated interplay between the components of the DNA (de)methylating machinery that contribute to MYC-driven tumor maintenance."}, {"pubmed": 31311407, "text": "Somatic mutations in KMT2D and TET2 associated with worse prognosis in Epstein-Barr virus-associated T or natural killer-cell lymphoproliferative disorders."}, {"pubmed": 31441600, "text": "Low expression of tet oncogene family member 2 protein (TET2) in children with lymphoblastic leukemia, acute, childhood (ALL) is associated with poor prognosis and can be used as a molecular prognostic marker for risk group stratification."}, {"pubmed": 31488558, "text": "5-formylcytosine and 5-hydroxymethyluracil as surrogate markers of TET2 and SF3B1 mutations in myelodysplastic syndrome, respectively."}, {"pubmed": 31570278, "text": "the results suggested that TET2-mediated cisplatin resistance may represent a novel mechanism of drug resistance in gastric cancer cells"}, {"pubmed": 31602702, "text": "DNA hypermethylation is associated with invasive phenotype of malignant melanoma."}, {"pubmed": 31607314, "text": "TET2 gene rs3733609 C/T heterozygosity (normal T/T) could be detected in 19 cases of 85 cases of JAK2V617F positive myeloproliferative neoplasms (22.4%) patients"}, {"pubmed": 31640337, "text": "Mutation of ten-eleven translocation-2 is associated with increased risk of autoimmune disease in patients with myelodysplastic syndrome."}, {"pubmed": 31646775, "text": "The necessity for personalized therapeutic regimes, especially for older patients suffering from acute myeloid leukaemia with mutated TET2 and/or other genetic alterations, along with its prognostication are also underlined."}, {"pubmed": 31653825, "text": "TET2-interacting long noncoding RNA promotes active DNA demethylation of the MMP-9 promoter in diabetic wound healing."}, {"pubmed": 31666683, "text": "Histone deacetylases, Mbd3/NuRD, and Tet2 hydroxylase are crucial regulators of epithelial-mesenchymal plasticity and tumor metastasis."}, {"pubmed": 31777116, "text": "TET2 promotor methylation and TET2 protein expression in pediatric posterior fossa ependymoma."}, {"pubmed": 31778687, "text": "Down-regulation of Tet2 was associated with higher methylation level of Foxp3 Treg cell-specific demethylated region, reduction in Foxp3 expression and Treg cells percentage in allergic rhinitis."}, {"pubmed": 31827242, "text": "Familial myeloid malignancies with germline TET2 mutation."}, {"pubmed": 31829736, "text": "The Positive Effect of TET2 on the Osteogenic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells."}, {"pubmed": 31836704, "text": "Study shows that during islet autoimmunity an miR142-3p/Tet2/Foxp3 axis interferes with the efficient induction of Treg cells, resulting in impaired Treg stability in mouse and human and identified Tet2 as a direct target of miR142-3p.  These findings offer a mechanistic model where during islet autoimmunity miR142-3p/Tet2-mediated Treg instability contributes to autoimmune activation and progression."}, {"pubmed": 31836856, "text": "Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patients."}, {"pubmed": 31867779, "text": "Values of 5mC, 5hmC, and TET2 for identifying the presence and progression of breast precancerous lesion."}, {"pubmed": 31901078, "text": "14-3-3 proteins protect AMPK-phosphorylated ten-eleven translocation-2 (TET2) from PP2A-mediated dephosphorylation."}, {"pubmed": 31925810, "text": "Phenotypic correlates and prognostic outcomes of TET2 mutations in myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: A comprehensive study of 504 adult patients."}, {"pubmed": 31941838, "text": "miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2."}, {"pubmed": 31990036, "text": "miR-101-3p induces vascular endothelial cell dysfunction by targeting tet methylcytosine dioxygenase 2."}, {"pubmed": 32024762, "text": "C35-mediated TET inactivation increased the efficiency of somatic cell programming without affecting TET complexes."}, {"pubmed": 32066746, "text": "Analysis of TET2 and EZH2 gene functions in chromosome instability in acute myeloid leukemia."}, {"pubmed": 32174258, "text": "LncRNA MAGI2-AS3 inhibits the self-renewal of leukaemic stem cells by promoting TET2-dependent DNA demethylation of the LRIG1 promoter in acute myeloid leukaemia."}, {"pubmed": 32192357, "text": "Novel Mutations and Decreased Expression of the Epigenetic Regulator TET2 in Pulmonary Arterial Hypertension."}, {"pubmed": 32193150, "text": "TET2 haploinsufficiency alters reprogramming into induced pluripotent stem cells."}, {"pubmed": 32203209, "text": "Decreased vitamin C uptake mediated by SLC2A3 promotes leukaemia progression and impedes TET2 restoration."}, {"pubmed": 32319378, "text": "TET2 SNPrs2454206(GA) commonly appears in patients with acute myeloid leukemia"}, {"pubmed": 32319620, "text": "TET2 is involved in DNA hydroxymethylation, cell proliferation and inflammatory response in keratinocytes."}, {"pubmed": 32330418, "text": "Non-coding and Loss-of-Function Coding Variants in TET2 are Associated with Multiple Neurodegenerative Diseases"}, {"pubmed": 32342329, "text": "Regulation of DNA methylation signatures on NF-kappaB and STAT3 pathway genes and TET activity in cigarette smoke extract-challenged cells/COPD exacerbation model in vitro."}, {"pubmed": 32367481, "text": "Role of Chromatin Remodeling Genes and TETs in the Development of Human Midbrain Dopaminergic Neurons."}, {"pubmed": 32518206, "text": "Endogenous Retrovirus Transcript Levels Are Associated with Immunogenic Signatures in Multiple Metastatic Cancer Types."}, {"pubmed": 32518946, "text": "Germline TET2 loss of function causes childhood immunodeficiency and lymphoma."}, {"pubmed": 32572734, "text": "The role of molecular mechanism of Ten-Eleven Translocation2 (TET2) family proteins in pathogenesis of cardiovascular diseases (CVDs)."}, {"pubmed": 32574963, "text": "UVB induces cutaneous squamous cell carcinoma progression by de novo ID4 methylation via methylation regulating enzymes."}, {"pubmed": 32619551, "text": "Loss of TET2 Affects Proliferation and Drug Sensitivity through Altered Dynamics of Cell-State Transitions."}, {"pubmed": 32658928, "text": "MicroRNA22-5p targets ten-eleven translocation and regulates estrogen receptor 2 expression in infertile women with minimal/mild endometriosis during implantation window."}, {"pubmed": 32668244, "text": "The Zscan4-Tet2 Transcription Nexus Regulates Metabolic Rewiring and Enhances Proteostasis to Promote Reprogramming."}, {"pubmed": 32807949, "text": "Epigenomic analysis of Parkinson's disease neurons identifies Tet2 loss as neuroprotective."}, {"pubmed": 32957806, "text": "Differential expression of DNA methyltransferases and demethylases among the various testicular germ cell tumor subtypes."}, {"pubmed": 33008340, "text": "A 38-gene model comprised of key TET2-associated genes shows additive utility to high-risk prostate cancer cases in the prognostication of biochemical recurrence."}, {"pubmed": 33022573, "text": "BPA modulates the WDR5/TET2 complex to regulate ERbeta expression in eutopic endometrium and drives the development of endometriosis."}, {"pubmed": 33085059, "text": "The function and regulation of TET2 in innate immunity and inflammation."}, {"pubmed": 33097695, "text": "FGFR3 big up tri, open7-9 promotes tumor progression via the phosphorylation and destabilization of ten-eleven translocation-2 in human hepatocellular carcinoma."}, {"pubmed": 33113366, "text": "TET2-Loss-of-Function-Driven Clonal Hematopoiesis Exacerbates Experimental Insulin Resistance in Aging and Obesity."}, {"pubmed": 33172974, "text": "5-Azacytidine Transiently Restores Dysregulated Erythroid Differentiation Gene Expression in TET2-Deficient Erythroleukemia Cells."}, {"pubmed": 33184433, "text": "Tet2 at the interface between cancer and immunity."}, {"pubmed": 33207953, "text": "Circular RNA CircMAP3K5 Acts as a MicroRNA-22-3p Sponge to Promote Resolution of Intimal Hyperplasia Via TET2-Mediated Smooth Muscle Cell Differentiation."}, {"pubmed": 33241418, "text": "Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations."}, {"pubmed": 33410283, "text": "Oxygen regulation of TET enzymes."}, {"pubmed": 33452460, "text": "Overexpression of Hmga2 activates Igf2bp2 and remodels transcriptional program of Tet2-deficient stem cells in myeloid transformation."}, {"pubmed": 33509440, "text": "TET-dioxygenase deficiency in oncogenesis and its targeting for tumor-selective therapeutics."}, {"pubmed": 33512451, "text": "Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells."}, {"pubmed": 33535102, "text": "Low shear stress-induced endothelial mesenchymal transformation via the down-regulation of TET2."}, {"pubmed": 33626359, "text": "TET2 is a component of the estrogen receptor complex and controls 5mC to 5hmC conversion at estrogen receptor cis-regulatory regions."}, {"pubmed": 33786584, "text": "Frequent somatic TET2 mutations in chronic NK-LGL leukemia with distinct patterns of cytopenias."}, {"pubmed": 33803981, "text": "Epigenetic Changes in Neoplastic Mast Cells and Potential Impact in Mastocytosis."}, {"pubmed": 33832602, "text": "Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction."}, {"pubmed": 33913570, "text": "Alveolar epithelial TET2 is not involved in the development of bleomycin-induced pulmonary fibrosis."}, {"pubmed": 33915173, "text": "TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes."}, {"pubmed": 34019487, "text": "Chronic alcohol exposure promotes HCC stemness and metastasis through beta-catenin/miR-22-3p/TET2 axis."}, {"pubmed": 34039392, "text": "TET2 and DNMT3A mutations and exceptional response to 4'-thio-2'-deoxycytidine in human solid tumor models."}, {"pubmed": 34099923, "text": "HIV is associated with an increased risk of age-related clonal hematopoiesis among older adults."}, {"pubmed": 34111946, "text": "TET2 Protects Against Vascular Smooth Muscle Cell Apoptosis and Intimal Thickening in Transplant Vasculopathy."}, {"pubmed": 34147657, "text": "CircDIP2C ameliorates oxidized low-density lipoprotein-induced cell dysfunction by binding to miR-556-5p to induce TET2 in human umbilical vein endothelial cells."}, {"pubmed": 34210413, "text": "Supplemental Association of Clonal Hematopoiesis With Incident Heart Failure."}, {"pubmed": 34215619, "text": "TET2 and DNMT3A Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors."}, {"pubmed": 34226983, "text": "Circ_0003423 Alleviates ox-LDL-Induced Human Brain Microvascular Endothelial Cell Injury via the miR-589-5p/TET2 Network."}, {"pubmed": 34267355, "text": "Measurable residual disease of canonical versus non-canonical DNMT3A, TET2, or ASXL1 mutations in AML at stem cell transplantation."}, {"pubmed": 34362476, "text": "[Clinical Significance of Truncated Mutant DeltaJBP of TET2 Gene in Patients with Acute Myeloid Leukemia]."}, {"pubmed": 34417463, "text": "Tet2 Controls the Responses of beta cells to Inflammation in Autoimmune Diabetes."}, {"pubmed": 34449560, "text": "TET2 Mutation and High miR-22 Expression as Biomarkers to Predict Clinical Outcome in Myelodysplastic Syndrome Patients Treated with Hypomethylating Therapy."}, {"pubmed": 34576030, "text": "Telomere Attrition and Clonal Hematopoiesis of Indeterminate Potential in Cardiovascular Disease."}, {"pubmed": 34654019, "text": "Clonal hematopoiesis driven by DNMT3A and TET2 mutations: role in monocyte and macrophage biology and atherosclerotic cardiovascular disease."}, {"pubmed": 34663818, "text": "TET2 mutations are associated with hypermethylation at key regulatory enhancers in normal and malignant hematopoiesis."}, {"pubmed": 34667079, "text": "PROSER1 mediates TET2 O-GlcNAcylation to regulate DNA demethylation on UTX-dependent enhancers and CpG islands."}, {"pubmed": 34689714, "text": "Tumour suppressor TET2 safeguards enhancers from aberrant DNA methylation and epigenetic reprogramming in ERalpha-positive breast cancer cells."}, {"pubmed": 34695415, "text": "Regulation of 5-Hydroxymethylcytosine by TET2 Contributes to Squamous Cell Carcinoma Tumorigenesis."}, {"pubmed": 34768283, "text": "TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes."}, {"pubmed": 34826027, "text": "MiR-196a promotes the proliferation and migration of esophageal cancer via the UHRF2/TET2 axis."}, {"pubmed": 34879277, "text": "Stage-specific regulation of DNA methylation by TET enzymes during human cardiac differentiation."}, {"pubmed": 34883445, "text": "Lifestyle and Genetic Factors Modify Parent-of-Origin Effects on the Human Methylome."}, {"pubmed": 34884685, "text": "Patterns of Maternal Neutrophil Gene Expression at 30 Weeks of Gestation, but Not DNA Methylation, Distinguish Mild from Severe Preeclampsia."}, {"pubmed": 34905094, "text": "Epigenetic upregulation of TET2 is an independent poor prognostic factor for intrahepatic cholangiocarcinoma."}, {"pubmed": 34929447, "text": "Regulation of TET2 gene expression and 5mC oxidation in breast cancer cells by estrogen signaling."}, {"pubmed": 35011643, "text": "Role of Myeloid Tet Methylcytosine Dioxygenase 2 in Pulmonary and Peritoneal Inflammation Induced by Lipopolysaccharide and Peritonitis Induced by Escherichia coli."}, {"pubmed": 35066499, "text": "DNMT3A and TET2; Potential Estimates of Generic DNA Methylation in Children and Adolescents with Obesity; Relation to Metabolic Dysregulation."}, {"pubmed": 35085104, "text": "Eltrombopag inhibits TET dioxygenase to contribute to hematopoietic stem cell expansion in aplastic anemia."}, {"pubmed": 35128634, "text": "TET2 deficiency cooperates with CBFB-MYH11 to induce acute myeloid leukaemia and represents an early leukaemogenic event."}, {"pubmed": 35136034, "text": "Sox2 induces glioblastoma cell stemness and tumor propagation by repressing TET2 and deregulating 5hmC and 5mC DNA modifications."}, {"pubmed": 35176127, "text": "TET2 Suppresses VHL Deficiency-Driven Clear Cell Renal Cell Carcinoma by Inhibiting HIF Signaling."}, {"pubmed": 35235761, "text": "A novel epigenetic marker, Ten-eleven translocation family member 2 (TET2), is identified in the intractable epileptic brain and regulates ATP binding cassette subfamily B member 1 (ABCB1) in the blood-brain barrier."}, {"pubmed": 35243663, "text": "Ten-eleven translocation-2 inactivation restrains IL-10-producing regulatory B cells to enable antitumor immunity in hepatocellular carcinoma."}, {"pubmed": 35248720, "text": "Aberrant epigenetic regulation of RARbeta by TET2 is involved in cutaneous squamous cell carcinoma resistance to retinoic acid."}, {"pubmed": 35279121, "text": "Pedigree investigation, clinical characteristics, and prognosis analysis of haematological disease patients with germline TET2 mutation."}, {"pubmed": 35306971, "text": "The prognostic value of the interaction between ASXL1 and TET2 gene mutations in patients with chronic myelomonocytic leukemia: a meta-analysis."}, {"pubmed": 35339897, "text": "Prevalence and prognostic significance of DNMT3A- and TET2- clonal haematopoiesis-driver mutations in patients presenting with ST-segment elevation myocardial infarction."}, {"pubmed": 35345350, "text": "Detection of TET2 Mutation in Patients with De Novo Acute Myeloid Leukemia: A Mutation Analysis of 51 Iranian Patients."}, {"pubmed": 35351824, "text": "TET2-mediated epigenetic reprogramming of breast cancer cells impairs lysosome biogenesis."}, {"pubmed": 35405783, "text": "[Analysis of clinical significance and prognostic impact of TET2 single nucleotide polymorphism I1762V in patients with acute myeloid leukemia]."}, {"pubmed": 35660018, "text": "TET2-BCLAF1 transcription repression complex epigenetically regulates the expression of colorectal cancer gene Ascl2 via methylation of its promoter."}, {"pubmed": 35697791, "text": "Cooperation between KDM6B overexpression and TET2 deficiency in the pathogenesis of chronic myelomonocytic leukemia."}, {"pubmed": 35714308, "text": "TET2-mutant clonal hematopoiesis and risk of gout."}, {"pubmed": 35931086, "text": "DNA methyltransferase 3 alpha and TET methylcytosine dioxygenase 2 restrain mitochondrial DNA-mediated interferon signaling in macrophages."}, {"pubmed": 35965615, "text": "Correlation of TET-2 Levels with Disease Evaluation in AMI Patients."}, {"pubmed": 36066697, "text": "Novel Germline TET2 Mutations in Two Unrelated Patients with Autoimmune Lymphoproliferative Syndrome-Like Phenotype and Hematologic Malignancy."}, {"pubmed": 36076297, "text": "ROS attenuates TET2-dependent ZO-1 epigenetic expression in cerebral vascular endothelial cells."}, {"pubmed": 36093687, "text": "TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients."}, {"pubmed": 36165590, "text": "Loss of TET2 with reduced genomic 5-hmC is associated with adverse-risk AML."}, {"pubmed": 36273104, "text": "Multi-hit TET2 mutations as a differential molecular signature of oligomonocytic and overt chronic myelomonocytic leukemia."}, {"pubmed": 36314527, "text": "AHR/TET2/NT5E axis downregulation is associated with the risk of systemic lupus erythematosus and its progression."}, {"pubmed": 36469134, "text": "RhoC in association with TET2/WDR5 regulates cancer stem cells by epigenetically modifying the expression of pluripotency genes."}, {"pubmed": 36473831, "text": "Association between ten-eleven methylcytosine dioxygenase 2 genetic variation and viral load in people with HIV."}, {"pubmed": 36580013, "text": "Clinical Implication of DNMT3A and TET2 Genes Mutations in Cytogenetically Normal Acute Myeloid Leukemia."}, {"pubmed": 36639817, "text": "Vitamin C boosts DNA demethylation in TET2 germline mutation carriers."}, {"pubmed": 36657637, "text": "VGLL4-TEAD1 promotes vascular smooth muscle cell differentiation from human pluripotent stem cells via TET2."}, {"pubmed": 36689729, "text": "TET2 truncating mutations predict a worse outcome in blastic plasmacytoid dendritic cell neoplasm."}, {"pubmed": 36737440, "text": "Myelodysplastic Syndrome associated TET2 mutations affect NK cell function and genome methylation."}, {"pubmed": 36769164, "text": "Epigenetic Regulation of Corneal Epithelial Differentiation by TET2."}, {"pubmed": 36806702, "text": "Modulation of AMPK/ TET2/ 5-hmC axis in response to metabolic alterations as a novel pathway for obesity-related colorectal cancer development."}, {"pubmed": 36812290, "text": "TET2 and LILRB1 mutations are frequent in Epstein-Barr virus-positive diffuse large B-cell lymphoma especially in elderly patients."}, {"pubmed": 37019647, "text": "MiR-10b-5p Impairs TET2-Mediated Inhibition of PD-L1 Transcription Thus Promoting Immune Evasion and Tumor Progression in Glioblastoma."}, {"pubmed": 37083525, "text": "Age-related loss of chromosome Y is associated with levels of sex hormone binding globulin and clonal hematopoiesis defined by TET2, TP53, and CBL mutations."}, {"pubmed": 37099347, "text": "TET2-Driver and NLRC4-Passenger Variants in Adult-Onset Autoinflammation."}, {"pubmed": 37267914, "text": "Loss of TET2 in human hematopoietic stem cells alters the development and function of neutrophils."}, {"pubmed": 37288803, "text": "Analysis of core mutation and TET2/ASXL1 mutations DNA methylation profile in myelodysplastic syndrome."}, {"pubmed": 37300692, "text": "Tet2-mediated DNA demethylation regulates the proliferation and apoptosis of human leukemia K562 cells."}, {"pubmed": 37430272, "text": "The role of TET2-mediated ROBO4 hypomethylation in the development of diabetic retinopathy."}, {"pubmed": 37467321, "text": "TOX2 coordinates with TET2 to positively regulate central memory differentiation in human CAR T cells."}, {"pubmed": 37541212, "text": "TET2-mediated mRNA demethylation regulates leukemia stem cell homing and self-renewal."}, {"pubmed": 37620362, "text": "Nuclear localization of TET2 requires beta-catenin activation and correlates with favourable prognosis in colorectal cancer."}, {"pubmed": 37667220, "text": "TET2 inhibits the proliferation and metastasis of lung adenocarcinoma cells via activation of the cGAS-STING signalling pathway."}, {"pubmed": 37702823, "text": "Clonal hematopoiesis with TET2 mutations spawning synchronous primary central nervous system lymphoma and myelodysplastic syndrome."}, {"pubmed": 37774069, "text": "Genetic Polymorphism Study of IDH 1/2 and TET2 Genes in Acute Myeloid leukemia Patients."}, {"pubmed": 37794021, "text": "TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing GATA2 expression."}, {"pubmed": 37801347, "text": "Mutual regulation between GDF11 and TET2 prevents senescence of mesenchymal stem cells."}, {"pubmed": 37812881, "text": "DNA dioxygenases TET2 deficiency promotes cigarette smoke induced chronic obstructive pulmonary disease by inducing ferroptosis of lung epithelial cell."}, {"pubmed": 37821382, "text": "m6A-Modified circTET2 Interacting with HNRNPC Regulates Fatty Acid Oxidation to Promote the Proliferation of Chronic Lymphocytic Leukemia."}, {"pubmed": 37909388, "text": "Association of Somatic TET2 Mutations With Giant Cell Arteritis."}, {"pubmed": 37992596, "text": "TET2-mediated DNA hydroxymethylation of TGFB1 is related to selective intrauterine growth restriction in monochorionic twin pregnancies."}, {"pubmed": 38014648, "text": "Functional TET2 gene polymorphisms increase the risk of neuroblastoma in Chinese children."}, {"pubmed": 38172938, "text": "TET2-mediated ECM1 hypomethylation promotes the neovascularization in active proliferative diabetic retinopathy."}, {"pubmed": 38231881, "text": "Clonal haematopoiesis of indeterminate potential and atrial fibrillation: an east Asian cohort study."}, {"pubmed": 38331641, "text": "Decreased TET2/5-hmC reduces the integrity of the epidermal barrier via epigenetic dysregulation of filaggrin in psoriatic lesions."}, {"pubmed": 38349460, "text": "TET2 mutations contribute to adverse prognosis in acute myeloid leukemia (AML): results from a comprehensive analysis of 502 AML cases and the Beat AML public database."}, {"pubmed": 38431463, "text": "TET2 mutation as prototypic clonal hematopoiesis lesion."}, {"pubmed": 38461173, "text": "Tet methylcytosine dioxygenase 2 (TET2) deficiency elicits EGFR-TKI (tyrosine kinase inhibitors) resistance in non-small cell lung cancer."}, {"pubmed": 38491513, "text": "Identification of miR-20b-5p as an inhibitory regulator in cardiac differentiation via TET2 and DNA hydroxymethylation."}, {"pubmed": 38515066, "text": "Association of tet methylcytosine dioxygenase 2 and 5-hydroxymethylcytosine in endometrioid adenocarcinoma and its clinical significance."}, {"pubmed": 38561362, "text": "A negative feedback loop between TET2 and leptin in adipocyte regulates body weight."}, {"pubmed": 38653944, "text": "TET2 Is Downregulated in Early Esophageal Squamous Cell Carcinoma and Promotes Esophageal Squamous Cell Malignant Behaviors."}, {"pubmed": 38886218, "text": "Uncovering the role of TET2-mediated ENPEP activation in trophoblast cell fate determination."}, {"pubmed": 38926973, "text": "[Relationship between DTA Mutations and Thromboembolism in Patients with Myeloproliferative Neoplasms]."}], "genomic_pos": {"chr": "4", "end": 105279816, "ensemblgene": "ENSG00000168769", "start": 105145875, "strand": 1}, "genomic_pos_hg19": {"chr": "4", "end": 106200973, "start": 106067032, "strand": 1}, "go": {"BP": [{"evidence": "IMP", "gocategory": "BP", "id": "GO:0002521", "pubmed": 32518946, "qualifier": "involved_in", "term": "leukocyte differentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006211", "qualifier": "involved_in", "term": "5-methylcytosine catabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006493", "pubmed": 23222540, "qualifier": "involved_in", "term": "protein O-linked glycosylation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0006493", "pubmed": 23353889, "qualifier": "involved_in", "term": "protein O-linked glycosylation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0014070", "qualifier": "involved_in", "term": "response to organic cyclic compound"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0030099", "qualifier": "involved_in", "term": "myeloid cell differentiation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0030099", "pubmed": 21057493, "qualifier": "involved_in", "term": "myeloid cell differentiation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0044029", "pubmed": 24315485, "qualifier": "involved_in", "term": "positive regulation of gene expression via chromosomal CpG island demethylation"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0045944", "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0045944", "pubmed": [23222540, 23353889], "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0005634", "qualifier": "is_active_in", "term": "nucleus"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005694", "qualifier": "located_in", "term": "chromosome"}], "MF": [{"category": "MF", "evidence": "IEA", "id": "GO:0003677", "qualifier": "enables", "term": "DNA binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [23222540, 23353889, 25601757, 29735542, 32814053, 34667079], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0008198", "pubmed": 24315485, "qualifier": "enables", "term": "ferrous iron binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0008270", "pubmed": 24315485, "qualifier": "enables", "term": "zinc ion binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0070579", "qualifier": "enables", "term": "5-methylcytosine dioxygenase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0070579", "pubmed": 24315485, "qualifier": "enables", "term": "5-methylcytosine dioxygenase activity"}, {"category": "MF", "evidence": "IMP", "id": "GO:0070579", "pubmed": [21057493, 23222540, 32518946], "qualifier": "enables", "term": "5-methylcytosine dioxygenase activity"}, {"category": "MF", "evidence": "ISS", "id": "GO:0070579", "qualifier": "enables", "term": "5-methylcytosine dioxygenase activity"}]}, "homologene": {"genes": [[8364, 100380145], [9031, 422540], [9544, 694137], [9598, 471263], [9606, 54790], [9615, 478499], [9913, 538481], [10090, 214133], [10116, 310859]], "id": 49498}, "interpro": [{"desc": "Methylcytosine dioxygenase TET1/2/3", "id": "IPR040175", "short_desc": "TET1/2/3"}, {"desc": "2OGFeDO JBP1/TET, oxygenase domain", "id": "IPR024779", "short_desc": "2OGFeDO_JBP1/TET_oxygenase_dom"}, {"desc": "Methylcytosine dioxygenase TET1-3, oxygenase domain", "id": "IPR046942", "short_desc": "TET_oxygenase"}], "ipi": ["IPI00026533", "IPI00175151", "IPI00654641", "IPI00794882", "IPI00963989", "IPI00968180"], "map_location": "4q24", "name": "tet methylcytosine dioxygenase 2", "other_names": ["methylcytosine dioxygenase TET2", "probable methylcytosine dioxygenase TET2", "ten-eleven translocation 2", "tet oncogene family member 2"], "pantherdb": {"HGNC": "25941", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "2443298", "ortholog_type": "LDO", "panther_family": "PTHR23358", "taxid": 10090, "uniprot_kb": "Q4JK59"}, {"RGD": "1311625", "ortholog_type": "LDO", "panther_family": "PTHR23358", "taxid": 10116, "uniprot_kb": "D4AC33"}, {"Ensembl": "ENSGALG00000010592", "ortholog_type": "LDO", "panther_family": "PTHR23358", "taxid": 9031, "uniprot_kb": "A0A3Q2U2F3"}, {"ZFIN": "ZDB-GENE-090312-98", "ortholog_type": "LDO", "panther_family": "PTHR23358", "taxid": 7955, "uniprot_kb": "E7F958"}, {"FlyBase": "FBgn0263392", "ortholog_type": "O", "panther_family": "PTHR23358", "taxid": 7227, "uniprot_kb": "M9NEY8"}], "uniprot_kb": "Q6N021"}, "pathway": {"reactome": [{"id": "R-HSA-1474165", "name": "Reproduction"}, {"id": "R-HSA-212165", "name": "Epigenetic regulation of gene expression"}, {"id": "R-HSA-5221030", "name": "TET1,2,3 and TDG demethylate DNA"}, {"id": "R-HSA-74160", "name": "Gene expression (Transcription)"}, {"id": "R-HSA-9827857", "name": "Specification of primordial germ cells"}], "wikipathways": {"id": "WP3584", "name": "MECP2 and Associated Rett Syndrome"}}, "pdb": ["4NM6", "5D9Y", "5DEU", "7NE3", "7NE6"], "pfam": "PF12851", "pharmgkb": "PA162405634", "pharos": {"target_id": 6373, "tdl": "Tchem"}, "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF171087", "relationship": "is"}, {"id": "GNF181993", "relationship": "is"}, {"id": "GNF192899", "relationship": "is"}, {"id": "GNF203805", "relationship": "is"}, {"id": "GNF211451", "relationship": "is"}, {"id": "GNF216903", "relationship": "is"}, {"id": "GNF222355", "relationship": "is"}, {"id": "GNF227807", "relationship": "is"}], "GNF_hs-Origene": [{"id": "GNF038859", "relationship": "is"}, {"id": "GNF044556", "relationship": "is"}, {"id": "GNF045305", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF275398", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF099626", "relationship": "is"}, {"id": "GNF113314", "relationship": "is"}, {"id": "GNF115004", "relationship": "is"}, {"id": "GNF139281", "relationship": "is"}, {"id": "GNF154645", "relationship": "is"}, {"id": "GNF156242", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000004.12", "NC_060928.1", "NG_028191.1"], "protein": ["NP_001120680.1", "NP_060098.3", "XP_005263139.1", "XP_006714305.1", "XP_016863808.1", "XP_024309870.1", "XP_024309871.1", "XP_047271795.1", "XP_047271796.1", "XP_047271797.1", "XP_047271798.1", "XP_047271799.1", "XP_054206247.1", "XP_054206248.1", "XP_054206249.1", "XP_054206250.1", "XP_054206251.1", "XP_054206252.1", "XP_054206253.1", "XP_054206254.1", "XP_054206255.1", "XP_054206256.1"], "rna": ["NM_001127208.3", "NM_017628.4", "XM_005263082.4", "XM_006714242.4", "XM_017008319.2", "XM_024454102.2", "XM_024454103.2", "XM_047415839.1", "XM_047415840.1", "XM_047415841.1", "XM_047415842.1", "XM_047415843.1", "XM_054350272.1", "XM_054350273.1", "XM_054350274.1", "XM_054350275.1", "XM_054350276.1", "XM_054350277.1", "XM_054350278.1", "XM_054350279.1", "XM_054350280.1", "XM_054350281.1", "XR_007057933.1", "XR_008486995.1"], "translation": [{"protein": "XP_047271798.1", "rna": "XM_047415842.1"}, {"protein": "XP_054206252.1", "rna": "XM_054350277.1"}, {"protein": "XP_047271795.1", "rna": "XM_047415839.1"}, {"protein": "XP_047271797.1", "rna": "XM_047415841.1"}, {"protein": "XP_054206254.1", "rna": "XM_054350279.1"}, {"protein": "XP_054206256.1", "rna": "XM_054350281.1"}, {"protein": "NP_001120680.1", "rna": "NM_001127208.3"}, {"protein": "XP_054206248.1", "rna": "XM_054350273.1"}, {"protein": "XP_047271799.1", "rna": "XM_047415843.1"}, {"protein": "XP_054206253.1", "rna": "XM_054350278.1"}, {"protein": "XP_005263139.1", "rna": "XM_005263082.4"}, {"protein": "XP_054206249.1", "rna": "XM_054350274.1"}, {"protein": "XP_054206255.1", "rna": "XM_054350280.1"}, {"protein": "XP_054206250.1", "rna": "XM_054350275.1"}, {"protein": "XP_024309870.1", "rna": "XM_024454102.2"}, {"protein": "XP_024309871.1", "rna": "XM_024454103.2"}, {"protein": "XP_016863808.1", "rna": "XM_017008319.2"}, {"protein": "NP_060098.3", "rna": "NM_017628.4"}, {"protein": "XP_054206251.1", "rna": "XM_054350276.1"}, {"protein": "XP_054206247.1", "rna": "XM_054350272.1"}, {"protein": "XP_047271796.1", "rna": "XM_047415840.1"}, {"protein": "XP_006714305.1", "rna": "XM_006714242.4"}]}, "reporter": {"GNF1H": ["gnf1h02476_at", "gnf1h04294_at", "gnf1h04295_s_at", "gnf1h06245_s_at", "gnf1h07734_at"], "HG-U133_Plus_2": ["1569385_s_at", "227624_at", "235461_at"], "HG-U95B": "47014_at", "HTA-2_0": "TC04000542.hg.1", "HuEx-1_0": ["2738146", "2738189", "2738191"], "HuGene-1_1": ["8096669", "8096675"], "HuGene-2_1": "16969414"}, "retired": 57667, "summary": "The protein encoded by this gene is a methylcytosine dioxygenase that catalyzes the conversion of methylcytosine to 5-hydroxymethylcytosine. The encoded protein is involved in myelopoiesis, and defects in this gene have been associated with several myeloproliferative disorders. Two variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2011].", "symbol": "TET2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1825692"}, "unigene": ["Hs.706276", "Hs.367639"], "uniprot": {"Swiss-Prot": "Q6N021", "TrEMBL": ["E7EPB1", "A0A158SIU0", "D6RE87", "E7EQS8"]}}